Literature DB >> 26380782

Chronic total occlusion: no more meta-analysis, please-a randomized clinical trial is urgently needed.

Alfredo Bardají1, Gil Bonet1.   

Abstract

Entities:  

Year:  2015        PMID： 26380782      PMCID： PMC4561273          DOI： 10.3978/j.issn.2072-1439.2015.07.34

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  13 in total

Review 1.  Chronic total occlusion: To treat or not to treat.

Authors:  Alfredo Bardají; Judit Rodriguez-López; Mauricio Torres-Sánchez
Journal:  World J Cardiol       Date:  2014-07-26

2.  Comments on the 2014 ESC/EACTS guidelines on myocardial revascularization.

Authors:  A Cequier
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2015-02

3.  Meta-Analysis of the Impact on Mortality of Noninfarct-Related Artery Coronary Chronic Total Occlusion in Patients Presenting With ST-Segment Elevation Myocardial Infarction.

Authors:  Stephen A O'Connor; Philippe Garot; Francesca Sanguineti; Loes P Hoebers; Thierry Unterseeh; Hakim Benamer; Bernard Chevalier; Thomas Hovasse; Marie-Claude Morice; Thierry Lefèvre; Yves Louvard
Journal:  Am J Cardiol       Date:  2015-04-06       Impact factor: 2.778

Review 4.  Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome.

Authors:  Loes P Hoebers; Bimmer E Claessen; Joelle Elias; George D Dangas; Roxana Mehran; José P S Henriques
Journal:  Int J Cardiol       Date:  2015-03-17       Impact factor: 4.164

5.  Quantifying the early health status benefits of successful chronic total occlusion recanalization: Results from the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial.

Authors:  J Aaron Grantham; Philip G Jones; Louis Cannon; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-04-13

6.  Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial.

Authors:  Bimmer E Claessen; George D Dangas; Giora Weisz; Bernhard Witzenbichler; Giulio Guagliumi; Martin Möckel; Sorin J Brener; Ke Xu; José P S Henriques; Roxana Mehran; Gregg W Stone
Journal:  Eur Heart J       Date:  2012-01-12       Impact factor: 29.983

7.  Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.

Authors:  Leslee J Shaw; William S Weintraub; David J Maron; Pamela M Hartigan; Rory Hachamovitch; James K Min; Marcin Dada; G B John Mancini; Sean W Hayes; Robert A O'Rourke; John A Spertus; William Kostuk; Gilbert Gosselin; Bernard R Chaitman; Merill Knudtson; John Friedman; Piotr Slomka; Guido Germano; Eric R Bates; Koon K Teo; William E Boden; Daniel S Berman
Journal:  Am Heart J       Date:  2012-08       Impact factor: 4.749

8.  Myocardial viability and survival in ischemic left ventricular dysfunction.

Authors:  Robert O Bonow; Gerald Maurer; Kerry L Lee; Thomas A Holly; Philip F Binkley; Patrice Desvigne-Nickens; Jaroslaw Drozdz; Pedro S Farsky; Arthur M Feldman; Torsten Doenst; Robert E Michler; Daniel S Berman; Jose C Nicolau; Patricia A Pellikka; Krzysztof Wrobel; Nasri Alotti; Federico M Asch; Liliana E Favaloro; Lilin She; Eric J Velazquez; Robert H Jones; Julio A Panza
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

9.  Long-term outcomes after percutaneous coronary intervention for chronic total occlusion (from the CREDO-Kyoto registry cohort-2).

Authors:  Erika Yamamoto; Masahiro Natsuaki; Takeshi Morimoto; Yutaka Furukawa; Yoshihisa Nakagawa; Koh Ono; Kazuaki Mitsudo; Masakiyo Nobuyoshi; Osamu Doi; Takashi Tamura; Masaru Tanaka; Takeshi Kimura
Journal:  Am J Cardiol       Date:  2013-06-01       Impact factor: 2.778

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.